Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPATIA hydroxychloroquine pregnancy trial in women with antiphospholipid antibodies
ISRCTN19920789Phase 3Active, not recruiting
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Jul 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in antiphospholipid syndrome (APS) comparing Hydroxychloroquine with Placebo (2 arms). Primary endpoint: Primary composite adverse pregnancy outcome. Started Jul 2017; status: active, not recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on ISRCTN19920789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN19920789.